IRIS Institutional Research Information System - OPENBS Open Archive UniBS

CAVAZZANA, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.387
EU - Europa 6.769
AS - Asia 2.886
SA - Sud America 404
AF - Africa 34
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 8
Totale 18.497
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.315
IT - Italia 3.734
CN - Cina 1.151
UA - Ucraina 917
SG - Singapore 852
DE - Germania 607
HK - Hong Kong 490
BR - Brasile 368
FI - Finlandia 296
GB - Regno Unito 237
FR - Francia 231
IE - Irlanda 227
RU - Federazione Russa 204
TR - Turchia 164
IN - India 79
SE - Svezia 51
CA - Canada 48
NL - Olanda 45
AT - Austria 29
BD - Bangladesh 27
BE - Belgio 27
EE - Estonia 23
ES - Italia 23
PL - Polonia 20
RO - Romania 18
VN - Vietnam 18
AR - Argentina 15
CH - Svizzera 12
IQ - Iraq 11
MX - Messico 11
LT - Lituania 10
AE - Emirati Arabi Uniti 9
EU - Europa 9
IL - Israele 9
PK - Pakistan 9
AU - Australia 8
CZ - Repubblica Ceca 8
JP - Giappone 8
ZA - Sudafrica 8
EG - Egitto 7
MK - Macedonia 7
SA - Arabia Saudita 7
JO - Giordania 6
KZ - Kazakistan 6
LU - Lussemburgo 6
IR - Iran 5
MA - Marocco 5
UZ - Uzbekistan 5
VE - Venezuela 5
AL - Albania 4
EC - Ecuador 4
GR - Grecia 4
ID - Indonesia 4
KG - Kirghizistan 4
LV - Lettonia 4
NO - Norvegia 4
SK - Slovacchia (Repubblica Slovacca) 4
AZ - Azerbaigian 3
CL - Cile 3
CO - Colombia 3
CY - Cipro 3
DK - Danimarca 3
KE - Kenya 3
LI - Liechtenstein 3
MU - Mauritius 3
PA - Panama 3
PE - Perù 3
PH - Filippine 3
PT - Portogallo 3
SI - Slovenia 3
AM - Armenia 2
BG - Bulgaria 2
CR - Costa Rica 2
DZ - Algeria 2
LK - Sri Lanka 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KR - Corea 1
KW - Kuwait 1
MS - Montserrat 1
NI - Nicaragua 1
NP - Nepal 1
PY - Paraguay 1
QA - Qatar 1
RS - Serbia 1
TW - Taiwan 1
UG - Uganda 1
Totale 18.496
Salva come PNG Salva come JPEG
Città #
Fairfield 1.061
Woodbridge 800
Jacksonville 678
Ashburn 572
Houston 557
Singapore 544
Hong Kong 489
Cambridge 418
Seattle 418
Wilmington 415
Ann Arbor 377
Beijing 338
Princeton 310
Chandler 280
Milan 263
Nanjing 224
New York 202
Chicago 191
Rome 190
Helsinki 177
Dublin 165
Istanbul 141
Los Angeles 119
Brescia 117
Florence 96
Munich 91
Moscow 88
Des Moines 87
Nanchang 84
Salt Lake City 77
San Diego 65
Hebei 64
The Dalles 62
Shenyang 58
Lancaster 57
Trieste 54
Turin 53
Verona 53
San Francisco 50
Changsha 47
Tianjin 44
Jinan 42
Jiaxing 39
Shanghai 39
Bologna 38
London 37
Dearborn 35
Genoa 35
Udine 34
Padova 32
Elk Grove Village 31
Dallas 30
Tampa 28
Brussels 27
São Paulo 26
Turku 26
Genova 24
Kunming 24
Nuremberg 24
Pisa 24
Tallinn 23
Toronto 23
Bergamo 22
Syracuse 21
Menlo Park 20
Falkenstein 19
Hangzhou 19
Modena 19
Mumbai 18
Reggio Nell'emilia 18
Ningbo 17
Torino 17
Naples 16
Redwood City 16
Trento 16
Palermo 15
Santa Clara 15
Vienna 15
Bari 14
Frankfurt am Main 14
Miami 14
Taizhou 14
Boardman 13
Brooklyn 13
Catania 13
Desio 13
Guangzhou 13
Lanzhou 13
Orange 13
Sassari 13
Venice 13
Buffalo 12
Norwalk 12
Washington 12
Zhengzhou 12
Ferrara 11
Pune 11
Sterling 11
Cosenza 10
Haikou 10
Totale 11.374
Salva come PNG Salva come JPEG
Nome #
ANTICORPI ANTI-TH/TO NELLA SCLEROSI SISTEMICA (SSC): CORRELAZIONI CLINICHE E IMMUNOLOGICHE 2.277
ANTICORPI ANTI-RNA POLIMERASI III: UN MARKER DI ESORDIO PRECOCE DI SCLEROSI SISTEMICA 1.669
Frequency Evaluation of the Interleukin-6 −174G>C Polymorphism and Homeostatic Iron Regulator (HFE) Mutations as Disease Modifiers in Patients Affected by Systemic Lupus Erythematosus and Rheumatoid Arthritis 652
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? 170
Anti-RNA polymerase III antibodies as a risk marker for early Gastric Antral Vascular Ectasia (GAVE) in systemic sclerosis 162
Anti-RNA polymerase III antibodies: A marker of systemic sclerosis with rapid onset and skin thickening progression 153
Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies 141
Macrophage activation syndrome in adult systemic lupus erythematosus: Report of seven adult cases from a single Italian rheumatology center 140
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 139
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 139
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 137
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 136
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). 135
The clinico-serological spectrum of overlap myositis 135
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 134
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 133
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 131
Autoimmune polyendocrine Syndromes 130
Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years 130
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 129
Treatment and functional outcome of patients with cystoid macular edema: a single-center experience 127
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 126
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events 124
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. 123
Relationship between endothelial dysfunction, videocapillaroscopy and circulating CD3+CD31+CXCR4+ lymphocytes in systemic lupus erythematosus without cardiovascular risk factors 121
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera 120
Treatment of lupus skin involvement with quinacrine and hydroxychloroquine. 119
Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures 117
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 117
Aortic stiffness and left ventricular hypertrophy in rheumatoid arthritis: Comment on the article by Rudominer et al. 116
Evaluation of mortality, disease activity, treatment, clinical and immunological features of adult and late onset systemic Lupus erythematosus. 116
Endothelium and the brain in CNS lupus. 115
Rare autoantibodies to cellular antigens in systemic lupus erythematosus. 114
Severe skin involvement in type II cryoglobulinemia successfully treated with thalidomide 113
The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies. 113
Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. 111
Renal Involvement in Primary Antiphospholipid Syndrome: Retrospective Analysis of 160 Patients. 111
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women 111
The 2016 classification criteria for primary Sjogren's syndrome: What's new? 111
Pregnancy and autoimmunity: maternal treatment and maternal disease influence on pregnancy outcome 109
[Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies] 109
The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus 108
Complement activation in anti-phospholipid syndrome: a clue for an inflammatory process? 107
METODICHE AUTOMATIZZATE PER ANTICORPI ANTINUCLEO (ANA): E' POSSIBILE SOSTITUIRE L'IMMUNOFLUORESCENZA INDIRETTA? 106
Anti-Ro/SSA and La/SSB antibodies 106
The inter-observer reading variability in anti-nuclear antibodies indirect (ANA) immunofluorescence test: A multicenter evaluation and a review of the literature 103
In vivo reflectance confocal microscopy features of cutaneous microcirculation and epidermal and dermal changes in diffuse systemic sclerosis and correlation with histological and videocapillaroscopic findings. 103
Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis 102
Update on Antiphospholipid Syndrome: Ten Topics in 2017 102
Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg? 102
Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases. 101
Autoantibodies and Skin Involvement in Systemic Autoimmune Diseases 101
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. 101
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 101
Autoantibodies to survival of motor neuron complex in patients with polymyositis: Immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteins 100
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept 100
Systemic sclerosis therapy with iloprost: a prospective observational study of 30 patients treated for a median of 3 years. 99
Cardiological features in idiopathic inflammatory myopathies. 99
Anti-topoisomerase-I antibodies in systemic lupus erythematosus and potential association with the presence of anti-dsDNA antibodies 99
International cohort study of 73 anti-Ku-positive patients: Association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis 98
Serum prealbumin is an independent predictor of mortality in systemic sclerosis outpatients 98
Elastic properties of the ascending aorta in patients with rheumatoid arthritis. 97
Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies. 97
Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis 96
Complement Activation and Pregnancy Failure. 95
Echocardiographic Evaluation of Asymptomatic Patients Affected by Rheumatoid Arthritis 95
Evaluation of Ascending Aorta Wall in Rheumatoid Arthritis by Tissue and Strain Doppler Imaging During Anti-Tumor Necrosis Factor-α Therapy 95
Switching from Intravenous to Subcutaneous Formulation of Abatacept: A Single-center Italian Experience on Efficacy and Safety 94
Serologic profile and mortality rates of scleroderma renal crisis in Italy 94
Characterization of T-cell population in children with prolonged fetal exposure to dexamethasone for anti-Ro/SS-A antibodies associated congenital heart block. 93
Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases. 92
Clinical and morphological features of kidney involvement in primary Sjogren's syndrome. 92
Automated tests of ANA immunofluorescence as throughput autoantibody detection technology: strengths and limitations 92
Rheumatoid arthritis and diabetes mellitus: Two faces of one coin? Comment on the article by Peters et al 91
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course. 91
LUPUS ERITEMATOSO SISTEMICO AD ESORDIO TARDIVO: CARATTERISTICHE CLINICHE ED IMMUNOLOGICHE 91
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis 89
Intravenous cyclophosphamide for interstitial lung disease associated to systemic sclerosis: results with an 18-month long protocol including a maintenance phase 89
Analysis of C9Orf72 Expansions in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: Preliminary Data 89
Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. 88
Elastic properties of the ascending aorta in patients with rheumatoid arthritis. 88
A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies. 86
Clinical and serological features of 35 patients with anti-Ki autoantibodies. 85
Prognostic value of diastolic dysfunction in asymptomatic rheumatoid arthritis patients without cardiovascular risk factors 85
Diastolic dysfunction in rheumatoid arthritis: a usual travel-mate? 85
CLINICAL AND IMMUNOLOGICAL ASSOCIATION WITH AUTOANTIBODIES TO CELLULAR ANTIGEN IN A COHORT OF 532 SLE PATIENTS FROM A SINGLE CENTER 84
A prospective evaluation of endothelial dysfunction in Systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results. 84
Anti-Ro/SSA autoantibodies over time in mothers of children with congenital complete heart block. 83
Complement cascade in systemic lupus erythematosus: Analyses of the three activation pathways 83
AUMENTO DELLA PROTEINA C-REATTIVA, ANTICORPI ANTI-CCP E FATTORE REUMATOIDE NELL'ARTRITE LUPICA 82
Novel aspects of Sjögren’s syndrome in 2012 82
A prospective evaluation of endothelial dysfunction in systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results 82
Ten Year Risk of Cardiovascular Events during anti-TNF Alpha in Rheumatoid Arthritis Patients 80
Semiquantitative analysis of line blot assay for myositis-specific and myositis-associated antibodies: a better performance? 79
Systematic Review and Meta-analysis on the Association of Occupational Exposure to Free Crystalline Silica and Rheumatoid Arthritis 79
Anti-TNF-alpha treatment in rheumatoid arthritis with anti-Ro/SSA antibodies. Analysis of 17 cases among a cohort of 322 treated patients 78
Reference standards for the detection of anti-mitochondrial and anti-rods/rings autoantibodies 78
Rare Autoantibodies To Cellular Antigens In Systemic Lupus Erythematosous. 77
ANTI-RNA POLYMERASE III ANTIBODIES AS A RISK MARKER FOR EARLY DEVELOPMENT OF GASTRIC ANTRAL VASCULAR ECTASIA IN SYSTEMIC SCLEROSIS 76
Value Of Diastolic Dysfunction In Asymptomatic Rheumatoid Arthritis Patients Without Cardiovascular Risk Factors 76
Totale 14.843
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.821
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.821
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.555 62 271 114 265 165 281 119 271 312 286 281 128
2021/20221.997 113 248 112 106 116 147 151 154 135 195 180 340
2022/20231.482 207 26 45 64 115 331 36 164 257 50 102 85
2023/20241.543 81 52 120 121 86 278 82 68 330 58 62 205
2024/20254.119 70 75 59 366 368 358 262 159 354 317 853 878
2025/2026188 188 0 0 0 0 0 0 0 0 0 0 0
Totale 18.787